Pure Global AI
Disease / condition

Advanced Solid Tumor clinical trials

Free access to 382 studies10+ countriesUpdated daily198 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
382
Total trials
10+
Countries
10+
Sponsors
198
Recruiting
By phase
Phase 1269
Phase 1/260
Early Phase 124
Phase 216
N/A9
By status
Recruiting198
Not yet recruit...111
Completed31
Unknown20
Terminated11
Top countries
China176
United States of America64
Australia16
Japan11
South Korea6
Top sponsors
Jiangsu HengRui Me...9
Shanghai YingLi Ph...6
Novartis Pharmaceu...6
Qilu Pharmaceutica...5
Mabwell (Shanghai)...4
Recent trials
Latest clinical trials for Advanced Solid Tumor
M9466 as Single Agent or in Combination With Tuvusertib in Advanced Solid Tumors (DDRiver 501)
EMD Serono Research & Developm... · Germany,United States of America
NCT06421935Not yet recr...
Phase
Phase 1
A Study of FDA022-BB05 in Advanced/Metastatic Solid Tumors
Shanghai Fudan-Zhangjiang Bio-... · China
NCT06413615Not yet recr...
Phase
Phase 2
Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors
University Hospital, Basel, Sw... · Switzerland
NCT06408688Not yet recr...
Phase
Phase 4
CAN1012 Combined With PD-1 in Patients With Solid Tumors
Canwell Biotech Limited · China
NCT06410703Not yet recr...
Phase
Phase 1/2
γδ T-PD-1 Ab Cells in the Treatment of Advanced Solid Tumors
Changzhou No.2 People's Hospit...
NCT06404281Not yet recr...
Phase
Phase 1
A Food Effect Study of SPH5030 Tablets.
Shanghai Pharmaceuticals Holdi... · China
NCT06372223Completed
Phase
Phase 1
A Study of MHB036C for Advanced Solid Tumor
Minghui Pharmaceutical (Hangzh... · China
NCT06373406Recruiting
Phase
Phase 1/2
Implementation of Liquid Biopsies During Routine Clinical Care in Patients With Advanced Malignancies (LIQPLAT)
University Hospital, Basel, Sw...
NCT06367751Not yet recr...
Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors
OncoC4, Inc. · United States of America
NCT06352359Not yet recr...
Phase
Phase 1
TIL for Patients With Advanced Solid Tumor
Hervor Therapeutics · China
NCT06334783Recruiting
Phase
Phase 1
Clinical Trial of BT02 in Patients With Advanced Solid Tumors
Cancer Institute and Hospital,... · China
NCT06404905Recruiting
Phase
Phase 1
A Study of MHB039A for Advanced Solid Tumor
Minghui Pharmaceutical (Hangzh... · China
NCT06345482Not yet recr...
Phase
Phase 1/2
ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors
Hansoh BioMedical R&D Company
NCT06332170Not yet recr...
Phase
Phase 1
A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors
HC Biopharma Inc. · China
NCT06307925Recruiting
Phase
Phase 1
A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors
D2M Biotherapeutics Inc. · United States of America
NCT06328673Recruiting
Phase
Phase 1
A Study of HC006 in Subjects With Advanced Solid Tumors
HC Biopharma Inc. · China
NCT06304571Recruiting
Phase
Phase 1
A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients.
Shanghai Institute Of Biologic...
NCT06298058Not yet recr...
Phase
Phase 1
A Study of BRY805 in Participants With Advanced Solid Tumors
BioRay Pharmaceutical Co., Ltd... · China
NCT06289894Not yet recr...
Phase
Phase 1
A Phase 1 Study of BB102 in Participants With Advanced Solid Tumors
BrodenBio Co., Ltd. · China
NCT06258408Recruiting
Phase
Phase 1
A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1)
Latticon Antibody Therapeutics... · United States of America
NCT06277219Not yet recr...
Phase
Phase 1/2
View all 382 trials →
About this profile

Access comprehensive clinical trial information for Advanced Solid Tumor through Pure Global AI's free database. This collection includes 382 clinical trials across multiple phases including Phase 1, Phase 1/2, Early Phase 1. Currently, 198 trials are actively recruiting participants.

Research for Advanced Solid Tumor is being conducted in China, United States of America, Australia and 7+ other countries. Leading sponsors include Jiangsu HengRui Medicine Co., Ltd. and Shanghai YingLi Pharmaceutical Co. Ltd.. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 382 clinical trials studying Advanced Solid Tumor, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Jiangsu HengRui Medicine Co., Ltd., Shanghai YingLi Pharmaceutical Co. Ltd., Novartis Pharmaceuticals, among others.